Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
British Journal of Haematology|May 8, 1999
Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working PartyS Allford, D Grimwade, S Langabeer, et al.
Bone Marrow Transplantation|September 20, 2016
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL studyE Van Den Neste, N Schmitz, N Mounier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trialM Gleeson, N Counsell, D Cunningham, et al.
Bone Marrow Transplantation|September 15, 2015
Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL studyE Van Den Neste, N Schmitz, N Mounier, et al.
Scientific Reports|November 11, 2020
Mir142 loss unlocks IDH2<sup>R140</sup>-dependent leukemogenesis through antagonistic regulation of HOX genesA Marshall, J Kasturiarachchi, P Datta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2017
Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trialA Kühnl, D Cunningham, N Counsell, et al.
European Urology Oncology|June 26, 2024
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort DEvan Y Yu, Cristiano Ferrario, Mark D Linch, et al.
The Lancet. Oncology|April 14, 2022
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trialSyed A Hussain, Jason F Lester, Richard Jackson, et al.
The Journal of Experimental Medicine|September 28, 2018
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironmentYien Ning Sophia Wong, Kroopa Joshi, Pramit Khetrapal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES StudyGianmarco Leone, Yien Ning Sophia Wong, Robert J Jones, et al.
Pageof 4